Communiqués Milestone Scientific Inc.

Actions

MLSS

US59935P2092

Equipement et technologie médicale avancés

Marché Fermé - NYSE Autres places de cotation 22:00:00 20/07/2026			Varia. 5j.	Varia. 1 janv.
0,4251 ^USD	-2,72%		+11,31%	+55,71%

15/07	Milestone Scientific lance la première phase de sa stratégie d'IA avec le lancement pilote de Milo, sa plateforme d'engagement numérique, lors de l'ASPN 2026	CI
01/07	Milestone Scientific Inc. publie ses prévisions de résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Communiqués

15/07	Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026	AQ
01/07	Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY	AQ
25/06	Milestone Scientific Strengthens Board to Support Next Phase of Growth	AQ
27/05	Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures	AQ
14/05	Milestone Scientific Reports Financial Results for First Quarter 2026	AQ
08/05	Milestone Scientific Expands CompuFlo Medical Business with Advisor Program and Growing National Clinical Adoption	AQ
07/05	Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call	AQ
07/05	Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption	AQ
21/04	Milestone Scientific Inc. Completes $2.15 Million Private Placement	AQ
31/03	Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025	AQ
26/03	Milestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference Call	AQ
23/02	Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion	AQ
10/02	Loss-of-Resistance Versus Dynamic Pressure-Sensing Technology for Successful Placement of Thoracic Epidural Catheters: A Randomized Clinical Trial	PU
10/02	Milestone Scientific : Cost-minimization analysis of the continuous real-time pressure sensing technology in parturients requesting labor epidural analgesia	PU
10/02	Milestone Scientific : Combination of real-time needle-tip pressure sensing and minimal intensity stimulation limits unintentional intraneural injection during an ultrasound-guided…	PU
10/02	Real-Time Injection Pressure Sensing and Minimal Intensity Stimulation Combination During Ultrasound-Guided Peripheral Nerve Blocks: An Exploratory Observational…	PU
10/02	Milestone Scientific : Analysis of Epidural Waveform to Determine Correct Epidural Catheter Placement After CSE Labor Analgesia	PU
10/02	Injection Pressure Monitoring During Peripheral Nerve Blocks: From Bench to Operating Theatre	PU
06/01	Milestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in Dentistry	AQ
13/11	Milestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025	AQ
13/11	Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call	AQ
14/10/25	Milestone Scientific Highlights Operational Progress and Growth Initiatives Under New Leadership	AQ
14/10/25	Milestone Scientific Commits to Regaining NYSE American Compliance Following Notification	AQ
22/09/25	Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain Management	AQ
14/08/25	Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025	AQ